Alnovat® - The innovative natural way to treat psoriasis vulgaris

Psoriasis is a chronic, incurable dermatological disease. Alnapharm GmbH & Co. KG developed the first cream to treat Psoriasis without side effects in an effective way. The innovative design based on a patented composition of natural ingredients. More effective and better results than standard pharmaceuticals.

To treat psoriasis a long-term therapy is essential. This cream is a safe, effective and skin friendly product to treat the psoriasis. State of the art treatments use pharmaceuticals that are cost intensive and not suitable for long-term therapy because of well documented side effects. The composition guarantees a high therapeutically effect combined with skin friendliness and solves this problems. The product ingredients are based on natural raw materials.

In a randomized double blinded internationally recognized clinical trial the efficacy of the cream in comparison to placebo and an international gold standard product was tested. More than 130 patients have been enrolled in the study. The trial finished successfully.

Key facts of this innovation:

High and quick effect after few days
Based on natural ingredients
Can be used as skin emollient
Long-term applicable for a monotherapy treatment

For more information about this innovative way to treat psoriasis, visit our product website:


The first healthcare product of Alnapharm is the dietary supplement OSVALIN®. OSVALIN® is a unique silicon preparation containing hydrolyzed, colloidal silicon dioxide in the highest possible concentration.


We want to take responsibility for each project that we are launching and with the specific task that goes with it. We are aware of the importance of our projects, with which we enter into an obligation to use our work for the highest good of the patient.

Research and Development

As man is a complex creature itself, we derive our knowledge of the complexity of the plants, the active ingredients that nature gives us. We strive to receive our developments from what already exists.


Stay informed about our newest inovations and achievments